Xtl Biopharmaceuticals
(NASDAQ) XTLB
Xtl Biopharmaceuticals Financials at a Glance
Market Cap
$24.72M
Revenue (TTM)
$451.00K
Net Income (TTM)
$1.03M
EPS (TTM)
$-0.11
P/E Ratio
-23.34
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$2.90
Volume
201
Open
$2.75
Price
$2.90
Volume
201
Open
$2.75
Previous Close
$2.90
Daily Range
$2.75 - $2.90
52-Week Range
$2.12 - $10.28
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$2.90
Volume
201
Open
$2.75
Previous Close
$2.90
Daily Range
$2.75 - $2.90
52-Week Range
$2.12 - $10.28
XTLB News
XTLB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xtl Biopharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
11
CEO
Shlomo Spokone Shalev, MBA
Website
www.xtlbio.comHeadquarters
Ramat Gan, 5218102, IL
XTLB Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
-3%
Net Income Margin
-2%
Return on Equity
-27%
Return on Capital
-25%
Return on Assets
-9%
Earnings Yield
-4.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$24.72M
Shares Outstanding
9.46M
Volume
201
Short Interest
0.00%
Avg. Volume
181.02K
Financials (TTM)
Gross Profit
$3.00K
Operating Income
$2.17M
EBITDA
$930.00K
Operating Cash Flow
$1.62M
Capital Expenditure
$54.00K
Free Cash Flow
$1.67M
Cash & ST Invst.
$1.14M
Total Debt
$138.00K
Xtl Biopharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$289.00K
N/A
Gross Profit
$43.00K
N/A
Gross Margin
-14.88%
N/A
Market Cap
$24.72M
N/A
Market Cap/Employee
$2.47M
N/A
Employees
10
N/A
Net Income
$255.00K
+10.2%
EBITDA
$429.25K
-51.1%
Quarterly Fundamentals
Net Cash
$1.00M
-49.9%
Accounts Receivable
$99.00K
+241.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$138.00K
N/A
Return on Assets
-9.45%
N/A
Return on Invested Capital
-24.85%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A